Manulife Launches Industry-Leading ‘Cancer Drug Support Service’ in Collaboration with Prosper Health and Shenzhen New Frontier United Family Hospital

New service enhances customer access to cost-effective cancer medications available in mainland China, helping to reduce cancer medication expenses while providing essential support for their treatment journey

Manulife Hong Kong has collaborated with Prosper Health, a leading health insurance service provider in mainland China, and Shenzhen New Frontier United Family Hospital (the “Hospital”) to launch the industry-leading “Cancer Drug Support Service”. Through this collaboration, Manulife becomes the first[1] insurer in Hong Kong to offer this service to eligible customers with selected critical illness plans[2]. Additionally, this service will be available to eligible customers with specific medical plans[3]. The new service aims to offer customers an option to access cost-effective cancer medications[4] available in mainland China.

This collaboration highlightsManulife's commitmentto enhancingits health and protection offerings in response to the growing demand for medical services in mainland China among Hong Kong residents.It also reinforces Manulife's dedication to empowering customers on their journey toward healthier and more fulfilling lives, with this pioneering service serving as an example of that mission.

Through this new service, eligible Manulife customers[2],[3],[5] with cancer medications[4]prescribed by their specialists can connect with Manulife's Personalized Medical Case Managers[6] for assistance. These Medical Case Managers, who are qualified nurses with extensive healthcare experience, will help customers verify[7] with Prosper Health the availability and price of their prescribed cancer medications at the Hospital and, once confirmed, coordinate with Prosper Health to schedule[7]an initial consultation with the Hospital's specialists[8] upon request. Additionally, eligible customers[2],[3]are entitled to a complimentary door-to-door limousine service[9],[10] for convenience throughout the campaign period.

“We are thrilled to partner with Prosper Health and Shenzhen New Frontier United Family Hospital to elevate our customers' health journey through the launch of our Cancer Drug Support Service,” said Carrie Tong, Chief Operations Officer of Manulife Hong Kong and Macau. “This innovative service is designed to provide our customers with a cost-effective option to access prescribed cancer medications in mainland China. By offering this alternative, we aim to help alleviate the financial burden often associated with critical illness care, enabling our customers to reduce their cancer medication expenses and focus on long-term financial planning. This initiative not only supports their physical well-being but also provides essential peace of mind during what can be an incredibly challenging time.”

“We are very pleased to deepen our collaboration withManulife Hong Kong by jointly launching the Cancer Drug Support Service. This initiative builds on our previous successful experiences in cancer medical services and focuses on addressing the practical needs of customers in accessing oral medications for cancer,” said Thom Gao, Co-founder and Chief Operations Officer of Prosper Health. “This collaboration complements our existing cross-border medical services, providing more holistic medical support for customers with specific needs. We hope to bring high-quality, affordable medical services to more patients.”

“We are deeply pleased to join hands with Prosper Health and Manulife Hong Kong to launch the important Cancer Drug Support Service,” said Brian Siu, Executive Director and Chief Operations Officer of New Frontier GBA. “Shenzhen New Frontier United Family Hospital has always adhered to a patient-centered philosophy, committed to providing excellent medical services. In this collaboration, we fully leverage our advantages in medical resource integration and professional medical teams to build a convenient bridge for Manulife customers to access cancer drugs in mainland China. Through close cooperation between the three parties, significantly simplifying the medical process for patients, ensuring they can focus on their treatment with peace of mind. We believe this collaboration is not only an innovation in medical service models but also a profound response to patients' health needs, bringing hope and peace of mind to more families.”

In December 2024, Manulife announced a partnership with New Frontier Group (the “Group”), the parent company of Prosper Health and the Hospital, as well as a leading healthcare service provider in Greater China, to introducecashless services for eligible customers through Prosper Health. Additionally, eligible customers[11] willenjoyexpedited appointments[12]for outpatient cancer treatment services and free one-time independent medical consultation[13] at any United Family Hospital within the Group.

Terms and conditions apply. For more details and risks about the relevant insurance products, please refer to the respective product leaflets. The content of this press release does not contain the full terms of the policy(ies), and the full terms can be found in the corresponding policy document(s). For complete product information of VHIS plans, please visit our website at www.manulife.com.hk. Before making a purchase, customers are encouraged to read the policy provisions for the exact terms and conditions that apply to these products. The services shall only be constituted as value-added services and not form part of the contractual benefit, nor forming any part of VHIS certified plans. Manulife reserves the right to amend or terminate these services at any time without prior notice.

Manulife and its intermediaries do not have relevant licences and/or qualifications to provide medical/transportation services. Manulife shall not be responsible or liable for any medical/transportation service, product and solicitation effort provided by third-party companies. The services are available to eligible customers only and is subject to the relevant terms and conditions. For details, please contact your financial advisor. Manulife and its intermediaries do not provide any medical advice. You should consult your medical advisors for any professional medical advice.

[1] Based on comparisons with other publicly available critical illness plans offered by other Hong Kong's major life insurance companies for individual customers as of March 19, 2025.[2]Eligibility applies to the Insured of ManuLove Care, ManuPrimo Care/ManuPrimo Care (BestStart), ManuBright Care 2 Plus, ManuBright Care 2, Manulife Bright Care PRO and ManuVital Care. The eligible policy(ies) must be without relevant exclusion(s).[3]Eligibility applies to the Insured of Manulife Supreme VHIS Flexi Plan, Manulife Supreme Lite VHIS Supplementary Benefit, Manulife Supreme Medical Plan, Manulife Supreme Lite Medical Supplementary Benefit, ManuMaster Healthcare Series/Benefits, ManuShine Healthcare Series/Benefits, Manulife First VHIS Flexi Plan, Manulife Shelter VHIS Standard Plan, ManuGuard Medical Plan/Benefit, Cancer Treatment Benefit and ManuEnrich Medical Top-up Plan. The eligible policy(ies) must be without relevant exclusion(s).[4]The type of cancer medication shall be an oral medication for cancer prescribed by specialists, excluding any formulation administered through injection or infusion. The fees for the cancer medications shall be paid by eligible Insured directly to the Hospital upon completion of consultation. The cancer medications will be provided by the Hospital engaged by Prosper Health. The use of the cancer medications is subject to the terms and conditions imposed by Prosper Health and/or the Hospital, which are not agents of Manulife and do not act on behalf of Manulife. Manulife shall make no representation, warranty or understanding as to any of the cancer medications.[5]To be eligible for Cancer Drug Support Service, the Insured must be confirmed with cancer and the respective diagnosis(es) must be supported by a registered medical practitioner.[6]Services provided by Personalized Medical Case Manager are supportive in nature, and not intended to provide or substitute professional medical advice, diagnosis, or treatment nor be regarded as admission of or assume any responsibility or liability on the part of Manulife. Eligible Insured should always seek the advice of physicians or other qualified health provider in relation to any health problems, conditions, treatment or any other matters.[7]Each eligible Insured can receive at most one free Cancer Drug Support Service per life regardless of the number of eligible policies they are insured.[8]The fees for the initial consultations shall be paid by eligible Insured directly to the Hospital upon completion of consultation. The initial consultations will be provided by the Hospital engaged by Prosper Health. The use of the initial consultation is subject to the terms and conditions imposed by Prosper Health and/or the Hospital, which are not agents of Manulife and do not act on behalf of Manulife. Manulife shall make no representation, warranty or undertaking as to any of the initial consultations.[9]Each eligible Insured is entitled to a maximum of one complimentary limousine service (round trip) for initial consultation of Cancer Drug Support Service arranged by Prosper Health throughout March 20 – June 19, 2025 regardless of the number of eligible plans which they are insured.[10]The use of the door-to-door limousine service may result in surcharge, which shall be paid by eligible Insured to the driver who provides the door-to-door limousine service in cash, WeChat Pay or Alipay (in RMB only) immediately upon arrival at the drop-off points. Manulife shall not be responsible and/or liable for any surcharge of the door-to-door limousine service. The limousine service will be carried out by third-party limousine service providers engaged by Prosper Health. The use of the limousine service is subject to the terms and conditions imposed by Prosper Health and third-party limousine service providers, which are not agents of Manulife and do not act on behalf of Manulife. Manulife shall make no representation, warranty or undertaking as to any of the limousine service.[11]Eligibility applies to customers of ManuMaster Healthcare Series, ManuShine Healthcare Series,and Manulife Supreme VHIS Flexi Plan, Manulife Supreme Lite VHIS Supplementary Benefit, Manulife Supreme Medical Plan, and Manulife Supreme Lite Medical Supplementary Benefit. This benefit is limited to Cashless Outpatient Cancer Treatment Service,including doctor consultations, chemotherapy/radiotherapy, and related diagnostic tests and services as stated in the Confirmation for Credit Service Arrangement.[12]Only applicable to designated doctors within the Preferred Medical Service Providers.[13]The cost of independent cancer medical consultation services will be covered by Manulife. However, any additional expenses (such as medication, tests, and examinations) will need to be paid by the customer.

https://mma.prnewswire.com/media/2646014/Carrie_Tong_Chief_Operations_Officer_Manulife_Hong_Kong_and_Macau.jpg

AboutManulife Hong Kong

Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started in Asia in 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over2.6 million customers in Hong Kong and Macau. We are committed to helping make decisions easier and lives better for our customers.

Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited.These entities are all subsidiaries of Manulife Financial Corporation.

About Manulife

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as 'MFC' on the Toronto, New York, and the Philippine stock exchanges, and under '945' in Hong Kong.

Not all offerings are available in all jurisdictions. For additional information, please visitmanulife.com.

About Prosper Health

Prosper Health is a member-centric health insurance service provider. Collaborating with leading insurance companies and local medical service providers in China, we offer personalized health management services and insurance solutions to both corporate and individual clients.

We integrate medical care into the entire process of health insurance services. Through our dedicated Personal Care Managers, we understand our clients' unique needs and establish a highly engaging, trustworthy, and long-term personalized service model, from prevention, treatment to rehabilitation; Our medical network spans globally, encompassing both public and private healthcare facilities; Digital tools enhance customers experience and create a first-class health insurance service platform. With the ecosystem resources of New Frontier, we are committed to bringing high-quality medical and health services to more people.Please visit https://www.prosperhealth.cn/for more information.

About United Family Healthcare

United Family Healthcare (UFH), a New Frontier Group subsidiary, is an international hospital and clinic network that has been providing private, premium healthcare in China since 1997. Today, UFH has established a strong presence in the region, operating 11 hospitals, 1 internet hospital, and 24 clinics across the country. The UFH team currently comprises approximately 1000 full-time doctors from over 30 countries and is supported by a dedicated group of over 1,500 nurses. Please visit https://ufh.com.cn/en/ for more information.

https://c212.net/c/img/favicon.png?sn=AE45686&sd=2025-03-20

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/manulife-launches-industry-leading-cancer-drug-support-service-in-collaboration-with-prosper-health-and-shenzhen-new-frontier-united-family-hospital-302406755.html

SOURCE Manulife Hong Kong

https://rt.newswire.ca/rt.gif?NewsItemId=AE45686&Transmission_Id=202503200200PR_NEWS_ASPR_____AE45686&DateId=20250320